SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-001004
Filing Date
2017-02-13
Accepted
2017-02-13 16:28:43
Documents
53
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtgn_10qdec312016461612.htm 10-Q 1504980
2 MATERIAL CONTRACTS ex10-1.htm EX-10.1 257279
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex-311.htm EX-31.1 14235
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex312.htm EX-31.2 16151
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex-32.htm EX-32.1 6955
  Complete submission text file 0001654954-17-001004.txt   4225715

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtgn-20161231.xml EX-101.INS 678405
7 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20161231.xsd EX-101.SCH 32670
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20161231_cal.xml EX-101.CAL 43721
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20161231_def.xml EX-101.DEF 99735
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20161231_lab.xml EX-101.LAB 196480
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20161231_pre.xml EX-101.PRE 165501
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 17599567
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences